Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		15 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Cash Flows [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (657,371)	$ 2,050,507
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	23,407	31,778
Stock-based compensation	144,047	44,093
CompensationObligationSettlement	43,751	0
IdleFacilityImpairmentCharge	87,000	0	$ 487,000
Inventory Write-down	0	700,000
Changes in operating assets and liabilities:
Accounts receivable	(87,157)	110,605
Inventories	10,154	(182,404)
Increase (Decrease) In Collaboration Receivable	7,678	0
Prepaid expenses and other current and long-term assets	312,550	(101,579)
Accounts payable	(102,465)	(740,223)
Accrued expenses	(458,772)	657,059
Increase (Decrease) in Accrued Product Returns	(86,000)	(374,766)
Increase (Decrease) in Deferred Collaboration Income	0	(1,774,704)
Net Cash Provided by (Used in) Operating Activities	(763,178)	420,366
Cash flows from financing activities:
Net proceeds from issuance of stock and warrants	453,457	0
Net Cash Provided by (Used in) Financing Activities	453,457	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(309,721)	420,366
Cash and cash equivalents, end of period	2,816,485		2,816,485
Supplemental disclosure of cash flow information:
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	2,816,485	7,200,795	$ 2,816,485	$ 3,126,206	$ 6,780,429
Stock Issuance Settle Incentive Compensation Obligation	$ 43,751	$ 0